Literature DB >> 3490904

Cytogenetic evidence for clonal evolution in B-cell chronic lymphocytic leukemia.

T Han, K Ohtaki, N Sadamori, A W Block, B Dadey, H Ozer, A A Sandberg.   

Abstract

Sequential cytogenetic studies were performed in eight of ten patients with B-cell chronic lymphocytic leukemia presenting with trisomy 12 as the sole chromosomal abnormality. Follow-up studies of peripheral blood lymphocytes revealed that the karyotypes retained the sole abnormality of trisomy 12 in five cases, trisomy 12 converted to a normal karyotype during remission in one case, additional chromosome changes (-X,14q-) along with trisomy 12 appeared in one patient and multiple chromosome changes with or without trisomy 12 appeared in the remaining patient. The findings indicate that other chromosome changes in addition to trisomy 12 may develop as a result of clonal evolution or dedifferentiation, though the possibility that in two patients these changes may be related to chemotherapy and/or irradiation could not be ruled out entirely.

Entities:  

Mesh:

Year:  1986        PMID: 3490904     DOI: 10.1016/0165-4608(86)90015-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia.

Authors:  C D Fegan; F E Davies
Journal:  Clin Mol Pathol       Date:  1996-08

2.  First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab.

Authors:  Carmen Diana Schweighofer; Clemens-Martin Wendtner
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

3.  Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).

Authors:  Sílvia Beà; Armando López-Guillermo; Maria Ribas; Xavier Puig; Magda Pinyol; Ana Carrió; Lurdes Zamora; Francesc Soler; Francesc Bosch; Stephan Stilgenbauer; Dolors Colomer; Rosa Miró; Emili Montserrat; Elias Campo
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

4.  Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy.

Authors:  Marc Zapatka; Eugen Tausch; Selcen Öztürk; Deyan Yordanov Yosifov; Martina Seiffert; Thorsten Zenz; Christof Schneider; Johannes Blöhdorn; Hartmut Döhner; Daniel Mertens; Peter Lichter; Stephan Stilgenbauer
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.